 |
Doug Macron is the editor of GenomeWeb's Gene Silencing News. He covers research and therapeutic applications of RNAi, miRNA, and other gene-silencing technologies. E-mail Doug Macron or follow his GenomeWeb Twitter account at @Genesilencing. |
Benitec, Collaborators Report on Expressed RNAi Treatment for Heart Graft Rejection
August 02, 2012
Benitec, Collaborators Report on Expressed RNAi Treatment for Heart Graft Rejection
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Benitec, Medistem Publish Data on Preclinical Rheumatoid Arthritis Effort
February 9, 2012 / Gene Silencing News - Benitec Adds Rare Form of Muscular Dystrophy to Pipeline, Seeks Collaboration for Pain Program
November 3, 2011 / Gene Silencing News - Benitec, Biomics Advance HBV Partnership
February 24, 2011 / Gene Silencing News - Tacere Considers Sale of Company as Pfizer Exercises Option to HCV Program
February 11, 2010 / Gene Silencing News - Benitec, Children's Cancer Institute Australia to Co-Develop Lung Cancer Rx
October 1, 2009 / Gene Silencing News